Fact CheckerSign in

NCT07200973Not yet recruiting

People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles

Source: ClinicalTrials.gov · Last updated 27 Jul 2026

Brief summary (registry, in English)

This study will implement an adapted peer navigation intervention to improve linkage to and retention in HIV care for people living with HIV who experience substance use within Los Angeles County.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
23 Sept 2025
Start date
1 Oct 2026
Primary completion date
31 Oct 2028
Lead sponsor
University of California, Los Angeles
Diseases
HIV
NCT number
NCT07200973

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From 1 Oct 2026 to the primary completion date, 31 Oct 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any other condition or prior therapy that, in the opinion of the research staff would preclude informed consent, make study participation unsafe, make the individual unsuitable for the study or unable to comply with the study requirements. Such conditions may include, but are not limited to, renal, hepatic, hematological, gastrointestinal, endocrine, pulmonary, neurological, or cerebral disease, among others

Other

  • Born biologically female
  • Unwilling or unable to provide reliable contact information
  • Unwilling to provide urine or blood

Who the study is looking for

  • Living with HIV
  • Assigned male sex at birth
  • Willing to return for follow-up study visits every six months as long as the study is ongoing and be available to return for all study visits, barring unforeseen circumstances
  • Willing and able to provide written informed consent to take part in the study
  • Willing and able to provide adequate information for locator purposes
  • Willing to undergo repeat HIV viral load testing at select study visits
  • Willing to undergo substance use testing at each study visit

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.